Clinical trial
Studies of Elevated Parathyroid Activity
NCT00001277 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00001277 |
|---|---|
| Title | Studies of Elevated Parathyroid Activity |
| Official title | Studies of Hyperparathyroidism and Related Disorders |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hyperparathyroidism, Hypercalcemia, Parathyroid Neoplasm, Multiple Endocrine Neoplasia, MEN1 |
| Intervention type | Drug |
| Interventions | 68Ga-Dotatate, 18F-DOPA |
| Enrollment | 1,553 |
| Start date | Dec 15, 1993 |
| Primary completion | Mar 11, 2020 |
| Completion | Dec 23, 2020 |
| First posted | Nov 4, 1999 |
| Last update posted | Jun 7, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: